インスリン注射器の市場規模、シェア、成長分析：注射器サイズ別、疾患タイプ別、最終用途別、流通チャネル別、地域別 - 産業予測 2025～2032年

インスリン注射器の世界市場規模は2023年に17億米ドルと評価され、2024年の17億7,000万米ドルから2032年には24億6,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは4.2％で成長する見通しです。

世界のインスリン注射器市場は、座りがちなライフスタイル、不健康な食生活、都市化、肥満率の増加などに煽られて、糖尿病有病率、特に2型糖尿病が憂慮すべき勢いで増加しているため、大きな成長を遂げています。国際糖尿病連合は、成人の糖尿病人口が2021年の5億3,700万人から2045年には7億8,300万人に急増すると予測しており、効果的なインスリン送達システムに対する需要の高まりを生み出しています。ノボ・ノルディスクのような大手製薬会社が従来のヒト用インスリン・ペンから利益率の高いGLP-1受容体作動薬に軸足を移すにつれ、多くの患者、特に中低所得国の患者は、手頃な価格の選択肢が少なくなっています。その結果、特に高度な技術を持たないヘルスケア環境では、従来のインスリン注射器の使用が復活し、市場の需要をさらに押し上げています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術分析

インスリン注射器市場規模：注射器サイズ別

• 市場概要
• 3/10 CC注射器（0.3ml）
• 1/2 CC注射器（0.5ml）
• 1 CC注射器（1ml）
• その他

インスリン注射器市場規模：疾患タイプ別

• 市場概要
• 1型糖尿病
• 2型糖尿病

インスリン注射器市場規模：最終用途別

• 市場概要
• 病院と診療所
• 在宅ケア設定
• その他

インスリン注射器市場規模：流通チャネル別

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局

インスリン注射器市場規模：針の長さ別

• 市場概要
• 短
• 中
• 長

インスリン注射器市場規模：製品タイプ別

• 市場概要
• 標準インスリン注射器
• 安全インスリン注射器

インスリン注射器市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（U.S.）
• Sanofi S.A.（France）
• Becton, Dickinson and Company（BD）（U.S.）
• Terumo Corporation（Japan）
• Cardinal Health Inc.（U.S.）
• Medtronic plc（Ireland）
• Abbott Laboratories（U.S.）
• Nipro Corporation（Japan）
• Biocon Ltd.（India）
• Hindustan Syringes & Medical Devices Ltd.（India）
• B. Braun Melsungen AG（Germany）
• Ypsomed Holding AG（Switzerland）
• Stevanato Group S.p.A.（Italy）
• Schott Pharma AG & Co. KGaA（Germany）
• ApiJect Systems Corporation（U.S.）
• Teleflex Incorporated（U.S.）
• Owen Mumford Ltd.（U.K.）
• Allison Medical Inc.（U.S.）

結論と提言

Global Insulin Syringes Market size was valued at USD 1.7 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 2.46 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global insulin syringes market is experiencing significant growth due to the alarming rise in diabetes prevalence, particularly type 2 diabetes, fueled by sedentary lifestyles, unhealthy diets, urbanization, and increasing obesity rates. The International Diabetes Federation projects that the adult diabetes population will surge from 537 million in 2021 to 783 million by 2045, creating a heightened demand for effective insulin delivery systems. As major pharmaceutical companies like Novo Nordisk shift focus from traditional human insulin pens to higher-margin GLP-1 receptor agonists, many patients, particularly in low- and middle-income countries, are left with fewer affordable options. Consequently, there's a resurgence in the use of conventional insulin syringes, especially in healthcare settings lacking advanced technologies, further boosting market demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Syringes Market Segments Analysis

Global Insulin Syringes Market is segmented by Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type and region. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1 CC Syringe (1ml) and Others. Based on Disease Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on End-Use, the market is segmented into Hospitals & Clinics, Homecare Settings and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on Needle Length, the market is segmented into Short, Medium and Long. Based on Product Type, the market is segmented into Standard Insulin Syringes and Safety Insulin Syringes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Syringes Market

The global increase in the elderly population is contributing significantly to the rise in diabetes prevalence, resulting in heightened insulin usage. As age-related diabetes cases continue to climb, the demand for insulin syringes is steadily on the rise. This trend is driving market expansion, as effective and regular insulin administration becomes increasingly essential for managing the health of diabetic patients. Consequently, the urgent need for insulin syringes as a critical tool in diabetes care is a primary factor propelling growth in the global insulin syringes market.

Restraints in the Global Insulin Syringes Market

A significant constraint within the global insulin syringes market arises from patients' reluctance to initiate or adhere to insulin therapy, primarily due to fear of needles and the discomfort associated with injections. This apprehension leads to infrequent use of syringes, which hinders overall market growth. The issue of patient compliance remains critical in effective diabetes management, and when individuals are deterred from regular insulin usage, it creates barriers to market expansion. Addressing these concerns is essential to increase acceptance and utilization of insulin syringes, ultimately improving diabetes care and enhancing market potential.

Market Trends of the Global Insulin Syringes Market

The Global Insulin Syringes market is witnessing a notable trend towards miniaturized syringes, specifically 0.5 ml variants, driven by the growing demand from pediatric patients and individuals with Type 1 diabetes. These smaller syringes enhance dosing accuracy and provide a more comfortable experience for users, addressing the critical need for improved patient compliance. As more healthcare providers and patients recognize the benefits of these compact devices, manufacturers are increasingly focusing on innovation to meet this demand. This shift is expected to significantly influence market dynamics, fostering growth and expanding the availability of user-friendly insulin delivery solutions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Insulin Syringes Market Size by Syringe Size & CAGR (2025-2032)

• Market Overview
• 3/10 CC Syringe (0.3ml)
• 1/2 CC Syringe (0.5ml)
• 1 CC Syringe (1ml)
• Others

Global Insulin Syringes Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Syringes Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Homecare Settings
• Others

Global Insulin Syringes Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Insulin Syringes Market Size by Needle Length & CAGR (2025-2032)

• Market Overview
• Short
• Medium
• Long

Global Insulin Syringes Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Standard Insulin Syringes
• Safety Insulin Syringes

Global Insulin Syringes Market Size & CAGR (2025-2032)

• North America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • US
  • Canada
• Europe (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hindustan Syringes & Medical Devices Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott Pharma AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ApiJect Systems Corporation (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allison Medical Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations